Societal CDMO, a CDMO dedicated to solving complex formulation and manufacturing challenges primarily in small molecule therapeutic development, announced new project expansion agreements across four different current customers. The recently signed work expansion agreements include:   Increasing the batch size for an ongoing design of experiments (DoE) study of an approved chemotherapeutic agent, with incorporation of additional blending and compaction specifications for the tablets.   Ex...